An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma

Abstract Introduction and objectives hepatocellular carcinoma (HCC) is the major form of liver cancer with a poor prognosis. Amino acid metabolism has been found to alter in cancers and contributes to malignant progression. However, the asparagine metabolism status and relevant mechanism in HCC were...

Full description

Bibliographic Details
Main Authors: Jianguo Bai, Ruifeng Tang, Keyu Zhou, Jialei Chang, Hongyue Wang, Qixin Zhang, Jiahui Shi, Chao Sun
Format: Article
Language:English
Published: BMC 2022-10-01
Series:BMC Medical Genomics
Subjects:
Online Access:https://doi.org/10.1186/s12920-022-01380-z
_version_ 1811257101450739712
author Jianguo Bai
Ruifeng Tang
Keyu Zhou
Jialei Chang
Hongyue Wang
Qixin Zhang
Jiahui Shi
Chao Sun
author_facet Jianguo Bai
Ruifeng Tang
Keyu Zhou
Jialei Chang
Hongyue Wang
Qixin Zhang
Jiahui Shi
Chao Sun
author_sort Jianguo Bai
collection DOAJ
description Abstract Introduction and objectives hepatocellular carcinoma (HCC) is the major form of liver cancer with a poor prognosis. Amino acid metabolism has been found to alter in cancers and contributes to malignant progression. However, the asparagine metabolism status and relevant mechanism in HCC were barely understood. Methods By conducting consensus clustering and the least absolute shrinkage and selection operator regression of HCC samples from three cohorts, we classified the HCC patients into two subtypes based on asparagine metabolism level. The Gene Ontology, Kyoto Encyclopedia of Genes and Genomes analyses and Gene Set Enrichment Analysis of the differentially expressed genes between two subgroups were conducted. Immune cell infiltration was evaluated using CIBERSORT algorithm. The prognostic values of genes were analyzed by univariate and multivariate cox regression, ROC curve and Kaplan–Meier survival estimate analyses. Cell types of sing-cell RNA sequencing (scRNA-seq) data were clustered utilizing UMAP method. Results HCC patients with higher asparagine metabolism level have worse prognoses. Moreover, we found the distinct energy metabolism patterns, DNA damage response (DDR) pathway activating levels, drug sensitivities to DDR inhibitors, immune cell compositions in the tumor microenvironment and responses to immune therapy between two subgroups. Further, we identified a potential target gene, glutamic-oxaloacetic transaminase 2 (GOT2). GOT2 downregulation was associated with worse HCC prognosis and increased infiltration of T regulatory cells (Tregs). ScRNA-seq revealed the GOT2 downregulation in cancer stem cells compared with HCC cells. Conclusions Taken together, HCC subtype which is more reliant on asparagine and glutamine metabolism has a worse prognosis, and a core gene of asparagine metabolism GOT2 is a potential prognostic marker and therapeutic target of HCC. Our study promotes the precision therapy of HCC and may improve patient outcomes.
first_indexed 2024-04-12T17:52:14Z
format Article
id doaj.art-dfff6ee83e6d4ce58f292303979cff31
institution Directory Open Access Journal
issn 1755-8794
language English
last_indexed 2024-04-12T17:52:14Z
publishDate 2022-10-01
publisher BMC
record_format Article
series BMC Medical Genomics
spelling doaj.art-dfff6ee83e6d4ce58f292303979cff312022-12-22T03:22:29ZengBMCBMC Medical Genomics1755-87942022-10-0115111810.1186/s12920-022-01380-zAn asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinomaJianguo Bai0Ruifeng Tang1Keyu Zhou2Jialei Chang3Hongyue Wang4Qixin Zhang5Jiahui Shi6Chao Sun7Department of Hepatobiliary Surgery, The Fourth Hospital of Hebei Medical UniversityDepartment of Hepatobiliary Surgery, The Fourth Hospital of Hebei Medical UniversityDepartment of Hepatobiliary Surgery, The Fourth Hospital of Hebei Medical UniversityDepartment of Hepatobiliary Surgery, The Fourth Hospital of Hebei Medical UniversityDepartment of Hepatobiliary Surgery, The Fourth Hospital of Hebei Medical UniversityDepartment of Hepatobiliary Surgery, The Fourth Hospital of Hebei Medical UniversityDepartment of Hepatobiliary Surgery, The Fourth Hospital of Hebei Medical UniversityDepartment of Hepatobiliary Surgery, The Fourth Hospital of Hebei Medical UniversityAbstract Introduction and objectives hepatocellular carcinoma (HCC) is the major form of liver cancer with a poor prognosis. Amino acid metabolism has been found to alter in cancers and contributes to malignant progression. However, the asparagine metabolism status and relevant mechanism in HCC were barely understood. Methods By conducting consensus clustering and the least absolute shrinkage and selection operator regression of HCC samples from three cohorts, we classified the HCC patients into two subtypes based on asparagine metabolism level. The Gene Ontology, Kyoto Encyclopedia of Genes and Genomes analyses and Gene Set Enrichment Analysis of the differentially expressed genes between two subgroups were conducted. Immune cell infiltration was evaluated using CIBERSORT algorithm. The prognostic values of genes were analyzed by univariate and multivariate cox regression, ROC curve and Kaplan–Meier survival estimate analyses. Cell types of sing-cell RNA sequencing (scRNA-seq) data were clustered utilizing UMAP method. Results HCC patients with higher asparagine metabolism level have worse prognoses. Moreover, we found the distinct energy metabolism patterns, DNA damage response (DDR) pathway activating levels, drug sensitivities to DDR inhibitors, immune cell compositions in the tumor microenvironment and responses to immune therapy between two subgroups. Further, we identified a potential target gene, glutamic-oxaloacetic transaminase 2 (GOT2). GOT2 downregulation was associated with worse HCC prognosis and increased infiltration of T regulatory cells (Tregs). ScRNA-seq revealed the GOT2 downregulation in cancer stem cells compared with HCC cells. Conclusions Taken together, HCC subtype which is more reliant on asparagine and glutamine metabolism has a worse prognosis, and a core gene of asparagine metabolism GOT2 is a potential prognostic marker and therapeutic target of HCC. Our study promotes the precision therapy of HCC and may improve patient outcomes.https://doi.org/10.1186/s12920-022-01380-zHepatocellular carcinomaAsparagine metabolismTumor microenvironmentDNA damage responseGOT2
spellingShingle Jianguo Bai
Ruifeng Tang
Keyu Zhou
Jialei Chang
Hongyue Wang
Qixin Zhang
Jiahui Shi
Chao Sun
An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma
BMC Medical Genomics
Hepatocellular carcinoma
Asparagine metabolism
Tumor microenvironment
DNA damage response
GOT2
title An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma
title_full An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma
title_fullStr An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma
title_full_unstemmed An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma
title_short An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma
title_sort asparagine metabolism based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma
topic Hepatocellular carcinoma
Asparagine metabolism
Tumor microenvironment
DNA damage response
GOT2
url https://doi.org/10.1186/s12920-022-01380-z
work_keys_str_mv AT jianguobai anasparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma
AT ruifengtang anasparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma
AT keyuzhou anasparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma
AT jialeichang anasparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma
AT hongyuewang anasparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma
AT qixinzhang anasparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma
AT jiahuishi anasparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma
AT chaosun anasparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma
AT jianguobai asparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma
AT ruifengtang asparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma
AT keyuzhou asparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma
AT jialeichang asparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma
AT hongyuewang asparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma
AT qixinzhang asparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma
AT jiahuishi asparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma
AT chaosun asparaginemetabolismbasedclassificationrevealsthemetabolicandimmuneheterogeneityofhepatocellularcarcinoma